Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Thorlacius

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|March 20, 2003
CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 statusK Gudmundsdottir, S Thorlacius, J G Jonasson, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 31, 1997
BRCA2 mutation in Icelandic prostate cancer patientsS Sigurdsson, S Thorlacius, J Tomasson, et al.
Cancer Research|February 1, 1995
p53 abnormalities and genomic instability in primary human breast carcinomasJ E Eyfjörd, S Thorlacius, M Steinarsdottir, et al.
Acta Neurologica Scandinavica|September 1, 1988
Plasma exchange in myasthenia gravis: changes in serum complement and immunoglobulinsS Thorlacius, T E Mollnes, P Garred, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosisS Thorlacius, B Thorgilsson, J Björnsson, et al.
Lancet (London, England)|August 26, 1995
Linkage to BRCA2 region in hereditary male breast cancerS Thorlacius, L Tryggvadottir, G H Olafsdottir, et al.
American Journal of Human Genetics|May 1, 1997
Study of a single BRCA2 mutation with high carrier frequency in a small populationS Thorlacius, S Sigurdsson, H Bjarnadottir, et al.
Acta Neurologica Scandinavica|December 1, 1986
Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodiesS Thorlacius, A K Lefvert, J A Aarli, et al.
Lancet (London, England)|November 5, 1998
Population-based study of risk of breast cancer in carriers of BRCA2 mutationS Thorlacius, J P Struewing, P Hartge, et al.
Cancer Research|March 21, 1998
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instabilityS Gretarsdottir, S Thorlacius, R Valgardsdottir, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|March 20, 2003
CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 statusK Gudmundsdottir, S Thorlacius, J G Jonasson, et al.
Journal of Molecular Medicine (Berlin, Germany)|December 31, 1997
BRCA2 mutation in Icelandic prostate cancer patientsS Sigurdsson, S Thorlacius, J Tomasson, et al.
Cancer Research|February 1, 1995
p53 abnormalities and genomic instability in primary human breast carcinomasJ E Eyfjörd, S Thorlacius, M Steinarsdottir, et al.
Acta Neurologica Scandinavica|September 1, 1988
Plasma exchange in myasthenia gravis: changes in serum complement and immunoglobulinsS Thorlacius, T E Mollnes, P Garred, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosisS Thorlacius, B Thorgilsson, J Björnsson, et al.
Lancet (London, England)|August 26, 1995
Linkage to BRCA2 region in hereditary male breast cancerS Thorlacius, L Tryggvadottir, G H Olafsdottir, et al.
American Journal of Human Genetics|May 1, 1997
Study of a single BRCA2 mutation with high carrier frequency in a small populationS Thorlacius, S Sigurdsson, H Bjarnadottir, et al.
Acta Neurologica Scandinavica|December 1, 1986
Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodiesS Thorlacius, A K Lefvert, J A Aarli, et al.
Lancet (London, England)|November 5, 1998
Population-based study of risk of breast cancer in carriers of BRCA2 mutationS Thorlacius, J P Struewing, P Hartge, et al.
Cancer Research|March 21, 1998
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instabilityS Gretarsdottir, S Thorlacius, R Valgardsdottir, et al.
Pageof 4